Thomas A. McCourt
2021
In 2021, Thomas A. McCourt earned a total compensation of $8.8M as Chief Executive Officer at Ironwood Pharmaceuticals, a 158% increase compared to previous year.
Compensation breakdown
| Bonus | $143,300 |
|---|---|
| Non-Equity Incentive Plan | $680,063 |
| Salary | $732,053 |
| Stock Awards | $7,236,498 |
| Other | $18,090 |
| Total | $8,810,004 |
McCourt received $7.2M in stock awards, accounting for 82% of the total pay in 2021.
McCourt also received $143.3K in bonus, $680.1K in non-equity incentive plan, $732.1K in salary and $18.1K in other compensation.
Rankings
In 2021, Thomas A. McCourt's compensation ranked 1,255th out of 12,415 executives tracked by ExecPay. In other words, McCourt earned more than 89.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,255 out of 12,415 | 90th |
Division Manufacturing | 447 out of 5,505 | 92nd |
Major group Chemicals And Allied Products | 163 out of 2,375 | 93rd |
Industry group Drugs | 135 out of 2,096 | 94th |
Industry Pharmaceutical Preparations | 89 out of 1,546 | 94th |
Source: SEC filing on April 21, 2022.
McCourt's colleagues
We found six more compensation records of executives who worked with Thomas A. McCourt at Ironwood Pharmaceuticals in 2021.
2021
Jason Rickard
Ironwood Pharmaceuticals
Chief Operating Officer
2021
John Minardo
Ironwood Pharmaceuticals
Chief Legal Officer
2021
Gina Consylman
Ironwood Pharmaceuticals
Chief Financial Officer
2021
Michael Shetzline
Ironwood Pharmaceuticals
Chief Medical Officer
2021
Sravan Emany
Ironwood Pharmaceuticals
Chief Financial Officer
2021
Mark Mallon
Ironwood Pharmaceuticals
Chief Executive Officer
News
Ironwood Pharmaceuticals CEO Thomas McCourt's 2021 pay jumps 158% to $8.8M
April 21, 2022
Ironwood Pharmaceuticals CEO Mark Mallon's 2020 pay falls 32% to $6.8M
April 22, 2021
Ironwood Pharmaceuticals CEO Mark Mallon receives $10M in 2019
April 21, 2020
Ironwood Pharmaceuticals CEO Peter Hecht's 2018 pay slips 14% to $5.2M
April 26, 2019